In gastric and pancreatic cancers, IGF2BP2 stabilizes oncogenic mRNAs and promotes glutamine metabolism, suggesting similar roles in the aggressive behavior seen in cancers like COAD and KIRP [110,111]. Here, IGF2BP2 is linked to pancreatic neoplasm.